NBT Bank N A NY decreased its holdings in shares of Danaher Corporation (NYSE:DHR) by 1.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,977 shares of the conglomerate’s stock after selling 822 shares during the period. NBT Bank N A NY’s holdings in Danaher Corporation were worth $5,062,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Danaher Corporation by 3.9% during the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after buying an additional 1,530,015 shares during the period. BlackRock Inc. boosted its stake in shares of Danaher Corporation by 2,530.9% during the first quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock worth $3,247,398,000 after buying an additional 36,524,795 shares during the period. FMR LLC boosted its stake in shares of Danaher Corporation by 0.3% during the first quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock worth $1,662,803,000 after buying an additional 53,429 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Danaher Corporation by 0.7% during the first quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock worth $653,946,000 after buying an additional 50,673 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Danaher Corporation by 6.0% during the first quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after buying an additional 329,458 shares during the period. Institutional investors and hedge funds own 75.68% of the company’s stock.

DHR has been the subject of several recent research reports. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. Deutsche Bank AG reiterated a “buy” rating and set a $97.00 target price on shares of Danaher Corporation in a research note on Wednesday, June 21st. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 target price for the company in a research note on Friday, July 28th. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. Finally, Cowen and Company reiterated a “buy” rating and set a $90.00 target price on shares of Danaher Corporation in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $91.98.

Danaher Corporation (DHR) opened at 86.88 on Thursday. Danaher Corporation has a one year low of $75.71 and a one year high of $88.62. The firm has a 50-day moving average of $84.72 and a 200-day moving average of $84.16. The stock has a market capitalization of $60.35 billion, a PE ratio of 27.73 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the firm earned $0.90 EPS. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities research analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. Danaher Corporation’s payout ratio is currently 17.83%.

In related news, insider William King sold 43,688 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the sale, the insider now directly owns 45,748 shares in the company, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock worth $5,916,223 over the last quarter. Insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “NBT Bank N A NY Sells 822 Shares of Danaher Corporation (DHR)” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/nbt-bank-n-a-ny-sells-822-shares-of-danaher-corporation-dhr/1609213.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.